3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Anemia, Refractory, with Excess of Blasts
14
Myelodysplastic Syndromes
13
Leukemia, Myeloid, Acute
13
Neoplasms
10
Anemia
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Venous Thromboembolism
6
Myeloproliferative Disorders
6
Thrombocytopenia
5
Leukemia, Myelomonocytic, Chronic
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Anemia, Aplastic
5
Primary Myelofibrosis
4
Myelodysplastic-Myeloproliferative Diseases
4
Lymphoma, Non-Hodgkin
4
Leukemia, Myeloid, Accelerated Phase
4
Hematologic Neoplasms
4
Fanconi Anemia
4
Burkitt Lymphoma
4
Pulmonary Embolism
3
Multiple Myeloma
3
Leukemia, Myeloid, Chronic-Phase
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Leukemia, Biphenotypic, Acute
3
Leukemia
3
Hodgkin Disease
3
Febrile Neutropenia
3
Cytopenia
3
Congenital Bone Marrow Failure Syndromes
3
Blast Crisis
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery
×
Classical hematology
×
30 days
×
Clear all
No trials found.